China’s Hansoh signs up to $1.45 billion deal for colorectal cancer drug with Roche
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…
Jazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline Glioma
On Aug. 6, 2025, Jazz Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso™ (dordaviprone)…
The National Cancer Institute awarded a $10.7 million grant to Abramson Cancer Center to study CAR T cells in solid tumors
On Oct. 22, 2018, the National Cancer Institute (NC) awarded a $10.7 million five year grant to Abramson…
A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
Magnetic Surgery Tested Successfully on First Patient
Dec. 22, 1998, researchers from Barnes-Jewish Hospital in St. Louis announced using a revolutionary system that uses superconducting…
The human p53 gene was cloned
On Dec. 20, 1984, a team of scientists announced that a cDNA clone for human p53 cellular tumor…
David Baltimore, Renato Dulbecco, and Howard Martin Temin awarded the 1975 Nobel Prize in Medicine
In 1975, Caltech President David Baltimore, former Caltech faculty member and Salk Institute researcher Renato Delbucco, and Caltech…
A virus (the Epstein-Barr virus) was linked to human cancer (Burkitt lymphoma) for the first time
In 1964, a new herpesvirus, Epstein-Barr virus (EBV), was discovered in cultured tumor cells derived from a Burkitt…
NIH scientists first identified type II cell of pulmonary alveolus as the cell of origin of the common alveologenic tumours of the lungs
In 1939, Hugh G. Grady and Harold L. Stewart first identified the type II cell of the pulmonary…